NEOGEN CORP
NEOG evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for NEOG—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$2.03B
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Feb 28, 2026.
Run NEOGEN CORP through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available NEOGEN CORP facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 2 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
D/E 0.60
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
309
Total value held
$2.10B
| Holder | Shares | Value |
|---|---|---|
| blackrock, inc. | 32,621,005 | $303.0M |
| vanguard capital management llc | 19,130,092 | $177.7M |
| vanguard portfolio management llc | 12,832,264 | $119.2M |
| dimensional fund advisors lp | 9,132,021 | $84.8M |
| ing groep nv | 8,904,300 | $82.7M |
| state street corp | 8,590,344 | $79.8M |
| mackenzie financial corp | 7,803,226 | $72.5M |
| neuberger berman group llc | 7,751,718 | $72.0M |
| hudson bay capital management lp | 6,500,180 | $60.4M |
| gates capital management, inc. | 6,258,649 | $58.1M |
Showing top 10 of 309 institutional holders of NEOGEN CORP. Open the full 13F history after sign-in.
Short Interest
as of Apr 30, 2026- % of float
- 6.2%
- Days to cover
- 3.6
- Shares short
- 10,029,164
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
NEOG short interestGovernance
Frequently asked questions
Who is the CEO of NEOGEN CORP?
Mr. Mikhael Nassif is the chief executive officer of NEOGEN CORP (NEOG).
Where is NEOGEN CORP headquartered?
NEOGEN CORP (NEOG) is headquartered in Lansing, MI, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.